ANL
Adlai Nortye Ltd. - American Depositary Shares (ANL)
$00
About Adlai Nortye Ltd. - American Depositary Shares (ANL)
Adlai Nortye Ltd. is a clinical-stage biopharmaceutical company, which engages in the provision of development of cancer therapies for patients with stages of tumors. It offers AN0025, a clinical stage, potential EP4 antagonist designed to modulate tumor microenvironment. The company was founded on May 9, 2018, and is headquartered in Hangzhou, China.
Details
Daily high
$2.03
Daily low
$1.99
Price at open
$2.03
52 Week High
$14.90
52 Week Low
$1.69
Market cap
187.4M
Dividend yield
0.00%
Volume
11,679
Avg. volume
26,075
P/E ratio
--
Adlai Nortye Ltd. - American Depositary Shares News
Details
Daily high
$2.03
Daily low
$1.99
Price at open
$2.03
52 Week High
$14.90
52 Week Low
$1.69
Market cap
187.4M
Dividend yield
0.00%
Volume
11,679
Avg. volume
26,075
P/E ratio
--